Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1

J Med Chem. 2013 Dec 12;56(23):9471-9481. doi: 10.1021/jm400794z. Epub 2013 Nov 21.

Abstract

An expanded CUG repeat transcript (CUG(exp)) is the causative agent of myotonic dystrophy type 1 (DM1) by sequestering muscleblind-like 1 protein (MBNL1), a regulator of alternative splicing. On the basis of a ligand (1) that was previously reported to be active in an in vitro assay, we present the synthesis of a small library containing 10 dimeric ligands (4-13) that differ in length, composition, and attachment point of the linking chain. The oligoamino linkers gave a greater gain in affinity for CUG RNA and were more effective when compared to oligoether linkers. The most potent in vitro ligand (9) was shown to be aqueous-soluble and both cell- and nucleus-permeable, displaying almost complete dispersion of MBNL1 ribonuclear foci in a DM1 cell model. Direct evidence for the bioactivity of 9 was observed in its ability to disperse ribonuclear foci in individual live DM1 model cells using time-lapse confocal fluorescence microscopy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Ligands
  • Microscopy, Confocal
  • Myotonic Dystrophy / genetics*
  • Polyamines / chemical synthesis*
  • Polyamines / pharmacology
  • RNA / genetics
  • RNA-Binding Proteins / antagonists & inhibitors
  • RNA-Binding Proteins / genetics
  • Thermodynamics
  • Trinucleotide Repeats*

Substances

  • Ligands
  • MBNL1 protein, human
  • Polyamines
  • RNA-Binding Proteins
  • RNA